Understanding patient, caregiver, and prescriber preferences for an antipsychotic regimen administered once every 2 months for schizophrenia or bipolar I disorder: a qualitative interview study in North America

Roger S. McIntyre; Murat Yıldırım; Stephanie Loomer; Clodagh Beckham; Dawn Bates; Arun Micheelsen; Kristine Harrsen; Soma Nag; Xavier Guillaume; Pedro Such

doi:10.1080/03007995.2025.2585558

November 21, 2025Current Medical Research and OpinionOpen Access

Understanding patient, caregiver, and prescriber preferences for an antipsychotic regimen administered once every 2 months for schizophrenia or bipolar I disorder: a qualitative interview study in North America

View Full Paper

Ask AI

Bookmark

Share

Key Points

This research aims to explore the preferences of patients, caregivers, and prescribers regarding antipsychotic regimens.
Conducted qualitative interviews with participants from the U.S. and Canada.
Engaged patients, caregivers, and prescribers to gather insights.
Focused on preferences for long-acting injectables (LAIs).
Participants generally had favorable views on bi-monthly LAIs.
Findings suggest positive acceptance among schizophrenia and bipolar I disorder populations.

Implication

Qualitative interview study reveals favorable views on bi-monthly antipsychotic regimen in schizophrenia and bipolar I disorder.

Abstract

People living with schizophrenia or BP-I, caregivers, and prescribers in the United States and Canada generally had favorable views of LAIs administered once every 2 months. Quantitative follow-up research that extends these findings is warranted.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

McIntyre et al. (2025) studied this question.

synapsesocial.com/papers/6924e3e6c0ce034ddc34eb33 https://doi.org/10.1080/03007995.2025.2585558

View Full Paper

Ask AI

Bookmark

Share

Understanding patient, caregiver, and prescriber preferences for an antipsychotic regimen administered once every 2 months for schizophrenia or bipolar I disorder: a qualitative interview study in North America

Key Points

Implication

Abstract

Discussion

Cite This Study

Understanding patient, caregiver, and prescriber preferences for an antipsychotic regimen administered once every 2 months for schizophrenia or bipolar I disorder: a qualitative interview study in North America

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading